Gamble Jones Investment Counsel’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.39M Sell
9,934
-1,301
-12% -$185K 0.11% 94
2022
Q3
$1.44M Sell
11,235
-351
-3% -$50.6K 0.12% 87
2022
Q2
$1.63M Sell
11,586
-100
-0.9% -$14.3K 0.12% 87
2022
Q1
$1.63M Buy
11,686
+10
+0.1% +$1.53K 0.1% 98
2021
Q4
$2.04M Sell
11,676
-1,596
-12% -$266K 0.12% 89
2021
Q3
$2.2M Sell
13,272
-72
-0.5% -$12.4K 0.14% 83
2021
Q2
$2.4M Sell
13,344
-932
-7% -$170K 0.16% 82
2021
Q1
$2.75M Sell
14,276
-23
-0.2% -$4.43K 0.19% 78
2020
Q4
$2.89M Buy
14,299
+1
+0% +$207 0.2% 75
2020
Q3
$3M Buy
14,298
+988
+7% +$220K 0.22% 71
2020
Q2
$2.92M Sell
13,310
-79
-0.6% -$15.8K 0.23% 67
2020
Q1
$2.32M Sell
13,389
-25,022
-65% -$4.13M 0.21% 71
2019
Q4
$5.9M Sell
38,411
-2,191
-5% -$327K 0.46% 48
2019
Q3
$6.17M Sell
40,602
-148
-0.4% -$23.4K 0.51% 46
2019
Q2
$6.24M Sell
40,750
-569
-1% -$86.9K 0.53% 45
2019
Q1
$6.63M Buy
41,319
+207
+0.5% +$32.1K 0.59% 43
2018
Q4
$6.34M Buy
41,112
+4
+0% +$623 0.64% 35
2018
Q3
$6.18M Buy
41,108
+293
+0.7% +$41.6K 0.57% 43
2018
Q2
$5.52M Buy
40,815
+21,203
+108% +$2.62M 0.55% 42
2018
Q1
$2.61M Sell
19,612
-382
-2% -$51.3K 0.26% 76
2017
Q4
$2.97M Buy
19,994
+5
+0% +$680 0.28% 68
2017
Q3
$2.64M Buy
19,989
+836
+4% +$112K 0.27% 77
2017
Q2
$2.55M Buy
19,153
+65
+0.3% +$8.77K 0.27% 72
2017
Q1
$2.57M Sell
19,088
-1,475
-7% -$191K 0.27% 73
2016
Q4
$2.47M Sell
20,563
-383
-2% -$45.2K 0.27% 70
2016
Q3
$2.62M Sell
20,946
-174
-0.8% -$22.8K 0.28% 66
2016
Q2
$2.92M Sell
21,120
-274
-1% -$35.5K 0.32% 57
2016
Q1
$2.7M Sell
21,394
-576
-3% -$73.2K 0.3% 64
2015
Q4
$2.79M Sell
21,970
-1,001
-4% -$124K 0.31% 63
2015
Q3
$2.65M Sell
22,971
-1,777
-7% -$199K 0.31% 62
2015
Q2
$2.57M Sell
24,748
-369
-1% -$39.8K 0.27% 73
2015
Q1
$2.77M Sell
25,117
-351
-1% -$38.1K 0.29% 66
2014
Q4
$2.65M Buy
25,468
+57
+0.2% +$5.7K 0.27% 66
2014
Q3
$2.44M Sell
25,411
-312
-1% -$28.2K 0.27% 71
2014
Q2
$2.35M Buy
25,723
+536
+2% +$48K 0.26% 70
2014
Q1
$2.22M Sell
25,187
-359
-1% -$31.5K 0.26% 70
2013
Q4
$2.37M Sell
25,546
-304
-1% -$27.4K 0.28% 63
2013
Q3
$2.11M Sell
25,850
-1,184
-4% -$100K 0.27% 61
2013
Q2
$2.25M Buy
+27,034
New +$2.33M 0.3% 55

Other funds holding CLX

Gamble Jones Investment Counsel's CLX Position: Q4 2022 in Review

Gamble Jones Investment Counsel reduced its Clorox (CLX) stake by 12% in Q4 2022, selling an estimated $185K and leaving 9,934 shares worth $1.39M. The position accounts for 0.11% of the portfolio, ranked #94.

Gamble Jones Investment Counsel first reported a position in CLX in Q2 2013 and has held it in 39 quarters since. The position peaked at $6.63M in Q1 2019. 1,107 funds tracked by Wall St. Rank hold CLX as of Q4 2022.

  • Gamble Jones Investment Counsel held 9,934 shares of Clorox worth $1.39M as of Q4 2022.
  • Gamble Jones Investment Counsel sold 1,301 Clorox shares in Q4 2022, an estimated $185K.
  • Clorox made up 0.11% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #94 holding.
  • Gamble Jones Investment Counsel first reported a position in Clorox in Q2 2013 and has held it in 39 quarters since.
  • Gamble Jones Investment Counsel's Clorox position peaked at $6.63M in Q1 2019.
  • 1,107 funds tracked by Wall St. Rank held Clorox as of Q4 2022.

Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.